Mimio Health

What Mimio Health does

Mimio Health, Inc. is a San Francisco-based nutraceutical company founded in 2015 (research) / 2020 (company) that develops and sells a single patented dietary supplement — Mimio Biomimetic Cell Care — positioned as the first clinically validated fasting mimetic. The product is built on a patented synergistic formulation of four bio-identical fasting metabolites: Spermidine (8mg), Nicotinamide (250mg), Oleoylethanolamide (400mg), and Palmitoylethanolamide (600mg). The formulation was derived from 7+ years of human clinical fasting research at UC Davis, including plasma metabolomics studies identifying 300+ metabolic changes during a 36-hour fast, and is supported by three published clinical trials, the most recent being a decentralized randomized double-blind placebo-controlled study of 42 adults published in Nature Scientific Reports (March 2026). Mimio is headquartered at 95 3rd Street, San Francisco, operates with a small team (1–10 employees) including co-founders Dr. Chris Rhodes (CEO, PhD Nutritional Biochemistry, UC Davis), Dr. Angela Zivkovic (Professor of Nutrition, UC Davis), and Caitlin Beatty (COO), plus Director of E-Com Neil Heckman (ex-Casper, ex-Away).

The company runs a primarily direct-to-consumer go-to-market through its Shopify-hosted storefront, with two pricing tiers: a monthly subscription at $90 (10% discount, free shipping, cancellable) and a one-time purchase at $100 for a 30-day supply of 60 capsules. Products are HSA/FSA eligible via TrueMed integration, vegan, gluten-free, GMO-free, GMP-certified, and sold in compostable packaging. A secondary B2B wholesale program serves 300+ medical practitioners and wellness providers, and an affiliate program recruits influencers, practitioners, and creators in the health and longevity space. Customer segments include health-conscious longevity seekers (primary), medical practitioners, women in perimenopause/menopause, and intermittent/extended fasters.

Revenue is generated through subscription recurring DTC sales, one-time supplement purchases, wholesale practitioner accounts, and affiliate-referred sales. The company has received funding from Better Ventures, SOSV (IndieBio), What If Ventures, and UC Davis Venture Catalyst, and was a member of IndieBio's 11th accelerator cohort. Press coverage includes Rolling Stone, TechCrunch, Vogue, Men's Journal, Science Times, and Longevity Technology. No annual revenue, ARR, or specific funding amounts have been disclosed in available source materials.

Name

Mimio Health

Legal name

Mimio Health, Inc.

Website

https://mimiohealth.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Mimio Health is a San Francisco-based nutraceutical company selling a patented fasting mimetic supplement that combines four bio-identical metabolites to deliver fasting-associated cellular health and longevity benefits without dietary restriction. It sells direct-to-consumer via subscription and wholesale to 300+ medical practitioners.

Ownership category

akta.pro rank

Product category

Nutraceutical Supplements

NAICS

Food (Health) Supplement Retailers (456191)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Healthy Aging & Longevity Lifestyle Coaching (HSADAGAK)

akta.pro secondary industry

Functional Senior Nutrition Foods Manufacturing (High-Protein, Bone/Joint Support Foods) (AFAKAJAK)

Keywords

• Fasting mimetic supplements
• Longevity nutraceuticals
• Cellular health supplements
• Biomimetic dietary supplements
• Metabolic health supplements

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Technology or R&D, Personnel, Operations, Infrastructure

Revenue model

1. Direct-to-Consumer Supplement Sales: Mimio sells its flagship Biomimetic Cell Care product directly to consumers via its e-commerce storefront (mimiohealth.com). Revenue is generated through two purchase models: monthly subscription at $90 per 30-day supply (60 capsules) with automatic 10% discount and free shipping, and one-time purchase at $100. Subscription auto-renews monthly and can be paused or cancelled anytime.
2. Wholesale B2B Sales: Mimio offers a wholesale program for medical practitioners and wellness providers, allowing them to purchase Mimio products for resale or recommendation to their clients. The company reports over 300 practitioners enrolled in the wholesale program.
3. Affiliate/Referral Program: Mimio operates an affiliate program for qualified partners including practitioners, influencers, public figures, and creators in the health and longevity space. Partners earn commissions for referred sales.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Mimio Health sells a single core product, the Mimio Biomimetic Cell Care supplement, a patented daily "fasting mimetic" formulated with four bio-identical fasting metabolites (Spermidine, Nicotinamide, OEA, PEA) designed to recreate the cellular health, metabolic, and longevity benefits of a 36-hour fast without dietary restriction. The product is sold direct-to-consumer via a monthly subscription ($90) or one-time purchase ($100), with a wholesale program serving 300+ medical practitioners and an affiliate program for health and longevity creators.

Product overview

Mimio Health offers a single core product: Mimio Biomimetic Cell Care, a daily fasting mimetic supplement. The product uses a patented biomimetic formula containing four bioactive compounds (Spermidine, Nicotinamide, OEA, and PEA) that are naturally elevated during a 36-hour fast. The supplement is designed to activate cellular longevity pathways including autophagy, AMPK, NAD+/SIRT, and Nrf-2, providing fasting-like benefits without requiring dietary restriction. Available as a monthly subscription ($90/month with 10% discount and free shipping) or one-time purchase ($100 for 30-day supply of 60 capsules). The product is positioned as a foundational cellular health supplement for longevity and metabolic optimization.

Differentiator

Problem solved

Functional benefit

Products and services

• Mimio Biomimetic Cell Care A daily fasting mimetic supplement clinically proven to deliver fasting-like benefits to cellular health, metabolism, and longevity without dietary restriction. The patented formula combines four bio-identical fasting metabolites: Spermidine (8mg), Nicotinamide (250mg), Oleoylethanolamide/OEA (400mg), and Palmitoylethanolamide/PEA (600mg). Packaged as 60 capsules per 30-day supply (2 capsules per day), sold by monthly subscription at $90 (with 10% discount and free shipping) or one-time purchase at $100, with HSA/FSA eligibility via TrueMed and a 30-day money-back guarantee. Intended for health-conscious adults seeking cellular health, metabolic, and longevity benefits, and for medical practitioners recommending it to patients.

Quantifiable outcome

• 91% of active group participants reported improved appetite regulation vs. 47% in placebo (8-week trial)
• +5 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• People SciencecoreTechnology or Integration · 2 March 2026People Science partnered with Mimio Health to conduct a decentralized randomized double-blind placebo-controlled clinical trial using People Science's Chloe platform. The 8-week study of 42 adults with elevated metabolic risk was conducted entirely in participants' homes, demonstrating that rigorous clinical research can be conducted outside traditional research settings. Results were published in Nature Scientific Reports.
• UC DaviscoreStrategic or Co-development PartnerCo-founders Dr. Chris Rhodes and Dr. Angela Zivkovic conducted foundational fasting research at UC Davis, identifying 300+ metabolic changes during a 36-hour fast through plasma metabolomics. Dr. Zivkovic is a Professor of Nutrition at UC Davis. Mimio conducted a pilot clinical study at UC Davis (2021) and collaborated on research that supported the formula's ability to support cellular health, metabolic function, and biological aging.
• Mount SinaicoreStrategic or Co-development PartnerMimio conducted a clinical case study with Mount Sinai hospital system, which along with UC Davis research supported the formulation's ability to support cellular health, metabolic function, and biological aging.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Life Extension: Long-established, broad-line supplement retailer with a large longevity and metabolic-health catalog; competes for the same health-conscious consumer but offers hundreds of SKUs versus Mimio's single product.
• Metagenics: Large practitioner-focused nutritional supplement company serving integrative and functional medicine providers; comparable in serving the clinician wholesale channel that drives a large share of Mimio's professional demand.

Direct peers

• Timeline Nutrition (Amazentis): Premium longevity supplement brand built around Mitopure (urolithin A) with clinical-trial backing; comparable DTC model targeting mitochondrial health and longevity, with Spermidine overlap as one of Mimio's ingredients.
• AG1 (Athletic Greens): Premium daily nutritional supplement sold via subscription at a comparable price point; competes for the same health-conscious, longevity-oriented consumer seeking a single comprehensive daily product.
• Elysium Health: Direct competitor selling evidence-based longevity supplements (Basis with nicotinamide riboside and pterostilbene) to longevity-focused consumers; overlaps on clinical-trial-led branding and premium DTC positioning in the cellular-health category.
• Moon Juice: Premium adaptogen and longevity supplement brand with strong DTC and content presence; targets a similar health-conscious, longevity-oriented consumer with subscription products in the same price band.
• Bulletproof 360: Premium lifestyle supplement and nutrition brand with strong DTC and content-marketing presence; overlaps on biohacker/longevity positioning and premium subscription pricing.
• Designs for Health: Practitioner-channel-focused supplement company offering evidence-based formulas to clinicians; Mimio's wholesale program (300+ practitioners) targets the same functional/integrative medicine channel.
• ChromaDex (Tru Niagen): Sells the NAD+ precursor nicotinamide riboside as a longevity supplement with published clinical data; Mimio also includes Nicotinamide as one of its four fasting metabolites, making them overlapping players in the cellular-energy/longevity space.

Emerging players

• Neurohacker Collective (Qualia): Evidence-forward supplement brand selling stacks (Qualia Life, Qualia Mind) targeting longevity and cellular health; comparable in using clinical research and rigorous formulation to justify premium pricing to a similar biohacker buyer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/mimiohealth
• YouTubeyoutube.com/@mimiohealth
• Facebookfacebook.com/mimiohealth
• Instagraminstagram.com/mimiohealth
• TikToktiktok.com/@mimiohealth

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mimio Health